Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

109.800
+9.7009.69%
Volume:40.98M
Turnover:4.50B
Market Cap:191.49B
PE:200.36
High:112.700
Open:106.600
Low:106.000
Close:100.100
52wk High:112.700
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:2.46
T/O Rate:2.35%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.548
ROE:7.01%
ROA:2.10%
PB:7.92
PE(LYR):200.36
PS:10.46

Loading ...

China's Jiangsu Says it Will Support Pharmaceutical Firms' Global M&A, Licensing

Reuters
·
Yesterday

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Yesterday

Southbound Capital Insights: Net Buying Hits HK$453 Million, Innovent Bio Faces Heavy Selling After Earnings Surge

Stock News
·
Yesterday

CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30

Deep News
·
Yesterday

-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth

Reuters
·
Yesterday

Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High

Deep News
·
Yesterday

China, HK Stocks Track Global Tech Rebound; Gold Miners Rally

Reuters
·
Yesterday

Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth

Reuters
·
Yesterday

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Reuters
·
Yesterday

Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge

Deep News
·
Yesterday

Movement Alert|INNOVENT BIO Rises 8.89% in Regular Trading, H1 Net Profit Surges 50% with 2030 Revenue Target of RMB 35-40 Billion

Market Focus
·
Yesterday

INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target

Stock News
·
Yesterday

JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase

Deep News
·
Yesterday

China's Clover Biopharma H1 Revenue Drops Sharply, Flags Going-Concern Doubt

Reuters
·
Yesterday

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
Aug 25

Innovent Biologics' H1 Profit Jumps 50%

MT Newswires Live
·
Aug 25

Innovent Biologics - Re-Designates Ronald Hao Xi Ede as Non-Executive Director Effective September 1, 2026

THOMSON REUTERS
·
Aug 25

Innovent Announces 2026 Interim Results and Business Updates

THOMSON REUTERS
·
Aug 25

INNOVENT BIO Reports First-Half Profit of RMB 1.253 Billion, Up 50.2% Year-on-Year

Stock News
·
Aug 25

Innovent Biologics Delivers 1H26 Net Profit of RMB 1.25 Billion on 45% Revenue Surge, Accelerates Global Pipeline

Bulletin Express
·
Aug 25